{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:12:37Z","timestamp":1778688757510,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T00:00:00Z","timestamp":1568332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005423","name":"Akademiska Sjukhuset","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006415","name":"Stiftelsen Familjen Ernfors Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008550","name":"Diabetesfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["H2020-MSCA-ITN- 721236"],"award-info":[{"award-number":["H2020-MSCA-ITN- 721236"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.psyneuen.2019.104445","type":"journal-article","created":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T11:14:52Z","timestamp":1568718892000},"page":"104445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Effects of second-generation antipsychotics on human subcutaneous adipose tissue metabolism"],"prefix":"10.1016","volume":"110","author":[{"given":"Assel","family":"Sarsenbayeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e1tia M.","family":"Marques-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ketan","family":"Thombare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giada","family":"Di Nunzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina E.","family":"Almby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Lundqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan W.","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2019.104445_bib0005","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/mp.2010.33","article-title":"Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis","volume":"16","author":"Albaugh","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0010","first-page":"6","article-title":"A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers","author":"Albaugh","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6","article-title":"Pharmacokinetics and tissue distribution of ergosterol in rats","volume":"20","author":"Aravagiri","year":"1999","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0020","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.tem.2014.07.004","article-title":"Molecular pathophysiology of metabolic effects of antipsychotic medications","volume":"25","author":"Ballon","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/070674371405900203","article-title":"Pharmacogenetics of antipsychotics","volume":"59","author":"Brandl","year":"2014","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pnpbp.2018.01.004","article-title":"Atypical antipsychotics, insulin resistance and weight; a meta-analysis of healthy volunteer studies","volume":"83","author":"Burghardt","year":"2018","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0035","series-title":"Pharmacokinetics and Metabolism Update for Some Recent Antipsychotics","first-page":"829","author":"Caccia","year":"2011"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/6067349","article-title":"Mitochondria in White, Brown, and beige adipocytes","volume":"2016","author":"Cedikova","year":"2016","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0045","first-page":"1","article-title":"Overexpression of Insig-2 inhibits atypical antipsychotic-induced adipogenic differentiation and lipid biosynthesis in adipose-derived stem cells","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0050","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/JCP.0b013e3181a289cb","article-title":"Olanzapine plasma concentrations after treatment with 10, 20, and 40 mg\/d in patients with schizophrenia","volume":"29","author":"Citrome","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0055","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1091\/mbc.e15-10-0749","article-title":"Cell biology of fat storage","volume":"27","author":"Cohen","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0060","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbi.2006.02.002","article-title":"Cytokines in schizophrenia and the effects of antipsychotic drugs","volume":"20","author":"Drzyzga","year":"2006","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0065","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.mp.4001729","article-title":"Olanzapine impairs glycogen synthesis and insulin signaling in L6 skeletal muscle cells","volume":"10","author":"Engl","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","article-title":"Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes","volume":"105","author":"Esser","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0075","doi-asserted-by":"crossref","first-page":"R537","DOI":"10.1152\/ajpregu.2000.278.2.R537","article-title":"Tumor necrosis factor (TNF)-\u03b1 induces leptin production through the p55 TNF receptor","volume":"278","author":"Finck","year":"2000","journal-title":"Am. J. Physiol. Integr. Comp. Physiol."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0080","first-page":"1","article-title":"Inflammatory cytokines and antipsychotic-induced weight gain: review and clinical implications","volume":"2","author":"Fonseka","year":"2016","journal-title":"Mol. Neuropsychiatry"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0085","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/oby.2010.6","article-title":"Increased food intake and energy expenditure following administration of olanzapine to healthy men","volume":"18","author":"Fountaine","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0090","first-page":"23","article-title":"Fatty acid-binding protein 4 (FABP4): pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases","volume":"2014","author":"Furuhashi","year":"2014","journal-title":"Clin. Med. Insights Cardiol."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0095","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.amjmed.2006.02.031","article-title":"Metabolic syndrome and risk of cardiovascular disease: a meta-analysis","volume":"119","author":"Galassi","year":"2006","journal-title":"Am. J. Med."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cmet.2006.09.008","article-title":"Beneficial metabolic effects of M3 muscarinic acetylcholine receptor deficiency","volume":"4","author":"Gautam","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.115.228395","article-title":"5-HT2 receptor regulation of mitochondrial genes: unexpected pharmacological effects of agonists and antagonists","volume":"357","author":"Harmon","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4088\/JCP.0507e12","article-title":"Increasing global burden of cardiovascular disease in general populations and patients with schizophrenia","volume":"68","author":"Hennekens","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0115","first-page":"6","article-title":"HIV protease inhibitors act as competitive inhibitors of the cytoplasmic glucose binding site of GLUTs with differing affinities for GLUT1 and GLUT4","author":"Hresko","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0120","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.schres.2007.11.026","article-title":"Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin","volume":"100","author":"Jin","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0125","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/15622970701361255","article-title":"Serum levels of aripiprazole and dehydroaripiprazole, clinical response and side effects","volume":"9","author":"Kirschbaum","year":"2008","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-015-0670-x","article-title":"Adipose tissue inflammation in the pathogenesis of type 2 diabetes","volume":"15","author":"Kohlgruber","year":"2015","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/10408363.2015.1041582","article-title":"Adipocyte size as a determinant of metabolic disease and adipose tissue dysfunction","volume":"52","author":"Laforest","year":"2015","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0140","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00210-010-0499-4","article-title":"Antipsychotic drug action on SREBPs-related lipogenesis and cholesterogenesis in primary rat hepatocytes","volume":"381","author":"Lauressergues","year":"2010","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2011.06.008","article-title":"Life expectancy among persons with schizophrenia or bipolar affective disorder","volume":"131","author":"Laursen","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0150","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00125-006-0572-1","article-title":"Fat cell enlargement is an independent marker of insulin resistance and \u201chyperleptinaemia","volume":"50","author":"Lundgren","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0155","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/0091270003261901","article-title":"Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers","volume":"44","author":"Mallikaarjun","year":"2004","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0160","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.psychres.2012.05.036","article-title":"Altered immune function in unaffected first-degree biological relatives of schizophrenia patients","volume":"200","author":"Mart\u00ednez-Gras","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0165","first-page":"2709","volume":"64","author":"Mccormack","year":"2004","journal-title":"I Disorder"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0170","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2147\/NDT.S13876","article-title":"Aripiprazole for the maintenance treatment of bipolar disorder: A review of available evidence","volume":"7","author":"McIntyre","year":"2011","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0175","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/sj.mp.4001948","article-title":"Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment","volume":"12","author":"Minet-Ringuet","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0180","first-page":"306","article-title":"Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders","volume":"39","author":"Mitchell","year":"2013","journal-title":"Syst. Rev. Meta-Anal."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.mp.4002066","article-title":"Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles","volume":"13","author":"Nasrallah","year":"2008","journal-title":"Mol. Psychiatry"},{"issue":"supl. 1","key":"10.1016\/j.psyneuen.2019.104445_bib0190","first-page":"1","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0195","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.bbrc.2015.10.045","article-title":"Olanzapine promotes the accumulation of lipid droplets and the expression of multiple perilipins in human adipocytes","volume":"467","author":"Nimura","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0200","series-title":"Abilify (aripiprazole) [WWW Document]","author":"Pharmaceutical","year":"2005"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0205","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1247\/csf.13012","article-title":"The antipsychotic olanzapine induces apoptosis in insulin-secreting pancreatic \u03b2 cells by blocking PERK-mediated translational attenuation","volume":"38","author":"Ozasa","year":"2013","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0210","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.metabol.2016.09.008","article-title":"Impaired adipose tissue lipid storage, but not altered lipolysis, contributes to elevated levels of NEFA in type 2 diabetes. Degree of hyperglycemia and adiposity are important factors","volume":"65","author":"Pereira","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0215","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.schres.2014.07.045","article-title":"Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis","volume":"159","author":"P\u00e9rez-Iglesias","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0220","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pnpbp.2005.06.008","article-title":"At therapeutic concentrations, olanzapine does not affect basal or insulin-stimulated glucose transport in 3T3-L1 adipocytes","volume":"30","author":"Robinson","year":"2006","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0225","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/CIRCRESAHA.110.223818","article-title":"PGC-1 coactivators in cardiac development and disease","volume":"107","author":"Rowe","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0230","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2010.07.012","article-title":"Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis","volume":"123","author":"Rummel-Kluge","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0235","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/sj.npp.1301541","article-title":"Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers","volume":"33","author":"Sacher","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0240","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.bbrc.2014.07.005","article-title":"Atypical antipsychotics induce both proinflammatory and adipogenic gene expression in human adipocytes in vitro","volume":"450","author":"S\u00e1rv\u00e1ri","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0245","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.pnpbp.2011.07.017","article-title":"Effects of antipsychotics with different weight gain liabilities on human in vitro models of adipose tissue differentiation and metabolism","volume":"35","author":"Serti\u00e9","year":"2011","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0250","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12020-018-1674-5","article-title":"FKBP5 expression in human adipose tissue: potential role in glucose and lipid metabolism, adipogenesis and type 2 diabetes","volume":"62","author":"Sidibeh","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0255","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S1461145711001271","article-title":"Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats","volume":"15","author":"Skrede","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0260","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jpsychires.2018.08.017","article-title":"Second generation atypical antipsychotics olanzapine and aripiprazole reduce expression and secretion of inflammatory cytokines in human immune cells","volume":"105","author":"Stapel","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0265","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.2165\/00003495-200464150-00010","article-title":"Aripiprazole a review of its use in schizophrenia and schizoaffective disorder","volume":"64","author":"Swainston Harrison","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0270","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.2337\/db13-0430","article-title":"Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric disease","volume":"62","author":"Teff","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0275","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.npp.1301142","article-title":"Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis","volume":"32","author":"Vestri","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0280","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.brainres.2010.05.060","article-title":"Olanzapine-induced accumulation of adipose tissue is associated with an inflammatory state","volume":"1350","author":"Victoriano","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0285","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1210\/jc.2008-1815","article-title":"Effects of olanzapine and haloperidol on the metabolic status of healthy men","volume":"95","author":"Vidarsdottir","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0290","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.euroneuro.2011.03.010","article-title":"Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label study","volume":"22","author":"Wampers","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0295","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0924-977X(98)00036-4","article-title":"Distribution of clozapine and desmethylclozapine between blood and brain in rats","volume":"9","author":"Weigmann","year":"1999","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0300","series-title":"Schizophrenia","author":"WHO","year":"2018"},{"key":"10.1016\/j.psyneuen.2019.104445_bib0305","doi-asserted-by":"crossref","first-page":"12","DOI":"10.14205\/2312-3710.2014.01.01.3","article-title":"Mechanisms of increased appetite and weight gain induced by psychotropic medications","volume":"1","author":"Wysokiski","year":"2014","journal-title":"J. Adv. Clin. Pharmacol."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0310","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.phrs.2007.05.007","article-title":"Olanzapine induces SREBP-1-related adipogenesis in 3T3-L1 cells","volume":"56","author":"Yang","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.psyneuen.2019.104445_bib0315","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1515\/CCLM.2007.252","article-title":"Histamine induces the expression of uncoupling protein 2 (UCP2) and acid-binding protein (aP2) in white adipocytes","volume":"45","author":"Zeng","year":"2007","journal-title":"Clin. Chem. Lab. Med."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453019304822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453019304822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:28:16Z","timestamp":1778686096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453019304822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":63,"alternative-id":["S0306453019304822"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104445","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of second-generation antipsychotics on human subcutaneous adipose tissue metabolism","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104445"}}